Latest Breaking News On - ஸெநெக ப்ல் - Page 1 : vimarsana.com

(Bloomberg) AstraZeneca Plc said its coronavirus antibody cocktail was found to be 77% effective in preventing symptomatic Covid-19 in high-risk people in a key trial, and the U.K. approved a rival’s drug as its first antibody treatment for the disease. Results from Astra’s study found no one in the trial who received the cocktail contracted severe Covid-19 or died in relation to the virus, the company said in a statement Friday. The trial of 5,197 participants, which started in November, was looking at whether the drug could prevent infection in at-risk groups such as transplant patients and those undergoing chemotherapy. The result comes as the U.K. approved its first monoclonal antibody drug against Covid-19 Friday, giving a green light to a treatment from Regeneron Pharmaceuticals Inc. and Roche Holding AG. The product was first authorized in the U.S. in November and European authorities have said they’re on track to complete their review this year. Demand has jumped amid t

City ofUnited kingdomVir biotechnology incRegeneron pharmaceuticals incGlaxosmithkline plcBloomberg astrazeneca plcRoche holdingZeneca plcRegeneron pharmaceuticalsMene pangalosSmithkline plcVir biotechnologyநகரம் ஆஃப்ஒன்றுபட்டது கிஂக்டம்வீர் உயிரி தொழில்நுட்பவியல் இன்க்கிளாக்சோஸ்மித்க்லைன் ப்ல்